Anne-leen Deleu

Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Intra-patient comparison of tracer uptake and biodistribution of [68Ga]Ga-FAPI-46 and [18F]AlF-FAPI-74.

Intra-patient comparison of tracer uptake and biodistribution of [68Ga]Ga-FAPI-46 and [18F]AlF-FAPI-74.

Journal: Annals of nuclear medicine
Published: May 29, 2026

Effect of neoadjuvant chemotherapy on [68Ga]Ga-FAPI-46 PET/CT in peritoneal carcinomatosis: a prospective translational exploratory sub-cohort analysis.

Effect of neoadjuvant chemotherapy on [68Ga]Ga-FAPI-46 PET/CT in peritoneal carcinomatosis: a prospective translational exploratory sub-cohort analysis.

Journal: European journal of nuclear medicine and molecular imaging
Published: April 09, 2026

Preoperative Assessment of Peritoneal Carcinomatosis with [68Ga]Ga-FAPI-46 PET/CT: Agreement with Surgicopathologic PCI and Comparison with MRI and [18F]FDG PET/CT.

Preoperative Assessment of Peritoneal Carcinomatosis with [68Ga]Ga-FAPI-46 PET/CT: Agreement with Surgicopathologic PCI and Comparison with MRI and [18F]FDG PET/CT.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 26, 2026

FAPI PET in the Management of Lung Tumors.

FAPI PET in the Management of Lung Tumors.

Journal: Seminars in nuclear medicine
Published: February 03, 2025

Secondary Pulmonary Hypertrophic Osteoarthropathy Detected on [ 68 Ga]Ga-FAPI-46 PET/CT.

Secondary Pulmonary Hypertrophic Osteoarthropathy Detected on [ 68 Ga]Ga-FAPI-46 PET/CT.

Journal: Clinical nuclear medicine
Published: December 29, 2024

What Does N2 Lymph Node Involvement Mean for Patients with Non-Small Cell Lung Cancer (NSCLC)?-A Review of Implications for Diagnosis and Treatment.

What Does N2 Lymph Node Involvement Mean for Patients with Non-Small Cell Lung Cancer (NSCLC)?-A Review of Implications for Diagnosis and Treatment.

Journal: Cancers
Published: June 17, 2024

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Journal: NPJ breast cancer
Published: May 12, 2023

Value of [68Ga]Ga-somatostatin receptor PET/CT in the grading of pulmonary neuroendocrine (carcinoid) tumours and the detection of disseminated disease: single-centre pathology-based analysis and review of the literature.

Value of [68Ga]Ga-somatostatin receptor PET/CT in the grading of pulmonary neuroendocrine (carcinoid) tumours and the detection of disseminated disease: single-centre pathology-based analysis and review of the literature.

Journal: EJNMMI research
Published: January 26, 2022

Characterization of FDG PET Images Using Texture Analysis in Tumors of the Gastro-Intestinal Tract: A Review.

Characterization of FDG PET Images Using Texture Analysis in Tumors of the Gastro-Intestinal Tract: A Review.

Journal: Biomedicines
Published: July 21, 2020

68Ga-DOTA-TATE PET/CT imaging for differentiating a sarcoid-like reaction from progression following immunotherapy in a triple-negative breast carcinoma patient.

68Ga-DOTA-TATE PET/CT imaging for differentiating a sarcoid-like reaction from progression following immunotherapy in a triple-negative breast carcinoma patient.

Journal: European journal of nuclear medicine and molecular imaging
Published: May 25, 2020

Immunogenomics of Metastatic Clear-Cell Renal Cell Carcinoma: Remarkable Response to Nivolumab in a Patient With a Pathogenic Germ Line BRCA1 Mutation.

Immunogenomics of Metastatic Clear-Cell Renal Cell Carcinoma: Remarkable Response to Nivolumab in a Patient With a Pathogenic Germ Line BRCA1 Mutation.

Journal: Clinical genitourinary cancer
Published: May 24, 2019
Showing 1-11 of 11

Last Updated: 09/26/2026